Chemfab Alkalis Limited Announces Q3 FY26 Unaudited Financial Results and Interim Dividend
Chemfab Alkalis Limited reported consolidated total income of ₹18,306.48 lakh and net profit after tax of ₹11,910.52 lakh for Q3 FY26. For the nine months ended Dec 31, 2025, consolidated net profit after tax was ₹36,314.86 lakh. The company declared an interim dividend of ₹1.50 per equity share.
The announcement includes financial results and an interim dividend declaration, which are material information for investors and can influence investment decisions.
The company reported growth in income and profits for the quarter and nine months ended December 31, 2025, and declared an interim dividend, which are positive indicators.
Chemfab Alkalis Limited has announced its unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. The company reported a total income from operations of ₹18,306.48 lakh for the consolidated quarter and ₹55,051.24 lakh for the nine-month period.
Net profit before tax for the consolidated quarter stood at ₹15,693.62 lakh, and for the nine months, it was ₹47,642.63 lakh. The net profit after tax for the consolidated quarter was ₹11,910.52 lakh, and for the nine months, it was ₹36,314.86 lakh. Basic earnings per share for the quarter were ₹1.34 and ₹4.08 for the nine months.
For standalone results, total income from operations was ₹18,132.46 lakh for the quarter and ₹55,057.38 lakh for the nine months. Net profit before tax was ₹15,120.18 lakh for the quarter and ₹46,189.32 lakh for the nine months. Net profit after tax was ₹11,508.92 lakh for the quarter and ₹34,974.36 lakh for the nine months. Basic earnings per share for the standalone quarter were ₹1.29 and ₹3.93 for the nine months.
The Board of Directors, in their meeting held on January 29, 2026, declared an interim dividend of ₹1.50 per equity share of face value ₹1. The financial results were approved by the Audit Committee and the Board of Directors on the same date. The company has published these results in the Business Standard (English) and Makkal Kural (Tamil) newspapers on January 30, 2026.
What to do with a filing like this
Chemfab Alkalis Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Chemfab Alkalis Limited. Read the original for the full detail.